Literature DB >> 16477579

Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells.

Nicole Sabolovic1, Anne-Claude Humbert, Anna Radominska-Pandya, Jacques Magdalou.   

Abstract

Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene), a natural polyphenol present in grapes and peanuts, has been reported to exert a variety of potentially therapeutic effects. The aim of this study was to determine the contribution of the gastrointestinal (GI) tract to the glucuronidation of this compound and its cis-isomer, which also occurs naturally. For this purpose, glucuronidation of the two resveratrol isomers was investigated in human microsomes prepared from: stomach, duodenum, four segments of the remaining small intestine (S-1 to S-4) and colon, and from the human intestinal cell lines Caco-2 and PD-7. cis- and trans-Resveratrol were efficiently glucuronidated in the GI tract with the formation of both 3-O- and 4'-O-glucuronides, however, the two stereoisomers were glucuronidated at different rates depending on the donor and the segment considered. Microsomes prepared from Caco-2 and PD-7 cells also efficiently glucuronidated cis-resveratrol and, to a lesser extent, the trans-isomer, however, only the 3-O-glucuronide was formed. Among the UDP-glucuronosyltransferases (UGT) that are known to be expressed in the GI tract, the isoforms UGT1A1, 1A6, 1A8, 1A9 and 1A10 were active in glucuronidating trans- and/or cis-resveratrol. The results demonstrate that the GI tract may contribute significantly to the first pass metabolism of these naturally occurring polyphenols. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477579     DOI: 10.1002/bdd.498

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  13 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

Review 3.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

4.  Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.

Authors:  Lisa K Brents; Fabricio Medina-Bolivar; Kathryn A Seely; Vipin Nair; Stacie M Bratton; Luis Nopo-Olazabal; Ronak Y Patel; Haining Liu; Robert J Doerksen; Paul L Prather; Anna Radominska-Pandya
Journal:  Xenobiotica       Date:  2011-10-04       Impact factor: 1.908

5.  Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats.

Authors:  Helena Colom; Irene Alfaras; Mònica Maijó; M Emília Juan; Joana M Planas
Journal:  Pharm Res       Date:  2011-03-23       Impact factor: 4.200

6.  Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.

Authors:  Barbara Fedejko-Kap; Stacie M Bratton; Moshe Finel; Anna Radominska-Pandya; Zofia Mazerska
Journal:  Drug Metab Dispos       Date:  2012-06-01       Impact factor: 3.922

7.  Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.

Authors:  Garvey Liu; Vidhi Khanna; Ameya Kirtane; Alex Grill; Jayanth Panyam
Journal:  FASEB J       Date:  2019-05-28       Impact factor: 5.834

8.  Metabolism of skin-absorbed resveratrol into its glucuronized form in mouse skin.

Authors:  Itsuo Murakami; Romanas Chaleckis; Tomáš Pluskal; Ken Ito; Kousuke Hori; Masahiro Ebe; Mitsuhiro Yanagida; Hiroshi Kondoh
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

9.  Novel resveratrol-based substrates for human hepatic, renal, and intestinal UDP-glucuronosyltransferases.

Authors:  Aleksandra K Greer; Nikhil R Madadi; Stacie M Bratton; Sarah D Eddy; Zofia Mazerska; Howard P Hendrickson; Peter A Crooks; Anna Radominska-Pandya
Journal:  Chem Res Toxicol       Date:  2014-03-11       Impact factor: 3.739

Review 10.  Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity.

Authors:  Elena Gianchecchi; Alessandra Fierabracci
Journal:  Antioxidants (Basel)       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.